|
Home>Faculty
List >Dr. Rook
|
|
Education
| 1971 | B.A. | Brandeis University |
| 1975 | M.D. | University of Michigan |
| Intern | Internal Medicine, McGill University, Montreal, Canada |
| Residency | Internal Medicine, McGill University, Montreal, Canada |
| Fellowship | Nephrology, McGill University, Montreal, Canada |
| Fellowship | Immunology, National Institute of Allergy and Infectious Diseases |
| Residency | Dermatology, University of Pennsylvania |
| 1979 | Diplomat American Board of Internal Medicine |
| 1980 | Diplomat American Board of Nephrology |
| 1979 | Specialist in Nephrology certified by the Quebec Corporation of Physicians& Surgeons; Quebec, Canada |
| 1991 | Diplomat American Board of Dermatology |
| 2001 | Recertified, American Board of Dermatology |
Research Area of Interest
The immunopathogenesis and treatment of cutaneous T-cell lymphomas.
Dr
Rook's Lab Personnel:
Maria Wysocka, Ph.D., Senior Research Investigator
Bernice Benoit, B.S., Senior Research Specialist
Sarah Newton, B.A., Pre-Doctoral Fellow
Stephen Richardson M.D., Instructor
Jessica Yoon, M.D., Post-Doctoral Fellow
Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, AH Rook. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 115:798-812, 2005.
Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, Lee J, Miller WT Jr, Rook AH, EJ Kim. Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1. Arch Dermatol. 141:301-4, 2005.
French LE, Huard B, Wysocka M, Shane R, Contassot E, Arrighi JF, Piguet V, Calderara S, Rook AH. Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sezary syndrome: circumvention by hexameric soluble CD40L. Blood. 105:219-25, 2005.
Wysocka M, Benoit BM, Newton S, Azzoni L, Montaner LJ, Rook AH. Enhancement of the host immune responses in Cutaneous T Cell lymphoma by CpG oligodeoxynucleotides and IL-15. Blood. 104:4142-9, 2004.
McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC. Low dose oral bexarotene in combination with low dose interferon alpha in the treatment of Cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms. J Amer Acad Dermatol 2004 Mar;50(3):375-9.
Kari L, Lobada A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, Wysocka M, Showe MK, Showe LC. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med. 2003 Jun 2; 197(11):1447-88.
Wysocka M, M Zaki, LE French, J Chehimi, M Shapiro, SE Everetts, KS McGinnis, L Montaner, AH Rook. Sezary syndrome patients demonstrate a defect in dendritic cell populations: Effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and production of cytokines. Blood 100:3287-94, 2002.
|
Privacy Statement | Legal
Disclaimer
The University of Pennsylvania Health System. © 2005. The Trustees of University of Pennsylvania |
